ClinicalTrials.gg
CompletedNCT05777356Updated Nov 28, 2023

Sanitary Napkins for Urinary Assessment of Micronutrients

An observational study in Focus: Nutritional Deficiency, sponsored by University of Hohenheim. Completed at 1 site in Germany. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-28.

Sponsored by University of Hohenheim · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This study aims to find an easy urinary collection method for the assessment of urinary markers of micronutrient status.

Read the detailed description

Urinary collection in newborns and infants can be difficult. Our study aims to find an easy and cheap alternative to urinary collection bags and specialized pads that can be used to measure biomarkers of iodine and vitamin B12 status in urine and can be employed in large scale trials. Using correlation analyses, the association of urinary iodine and methylmalonic acid from healthy volunteers will be assessed between untreated sample and a sample expressed from a sanitary napkin. Participants will be recruited based on their dietary pattern (omnivorous, vegetarian and vegans) to have a broad spectrum of analyte concentration. Participants weight, height, age, nutritional supplement use and diet will be assessed.

02

Conditions studied

  • Focus: Nutritional Deficiency

Browse trials for

03

In context

Malnutrition

1,277 studies on the registry are indexed under Malnutrition; 230 are open to participants now.

This study's enrollment of 30 is below the median of 206 across 393 observational studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

University of Hohenheim is the lead sponsor of 43 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants are primarily recruited at the University of Hohenheim

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Healthy volunteers Written

Exclusion criteria

Exclusion Criteria:

\< 18,5 and >24,9 Use of medication (except ) Smoking

Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No

Groups and cohorts

  • Omivorous

    Healthy volunteers without dietary restrictions

    Diagnostic Test: Urine collection and assessment of dietary intake by food frequency questionaire

  • Vegetarians

    Healthy volunteers who do not consume meat products

    Diagnostic Test: Urine collection and assessment of dietary intake by food frequency questionaire

  • Vegans

    Healthy volunteers who do not consume any animal product

    Diagnostic Test: Urine collection and assessment of dietary intake by food frequency questionaire

Interventions

  • Diagnostic testUrine collection and assessment of dietary intake by food frequency questionaire

    urinary iodine, creatinine and methylmalonic acid, iodine and vitamin B12 dietary intake from foods and supplements

06

What researchers measure

Primary outcomes

  1. Correlation untreated and expressed urine

    Correlation of creatinine, methylmalonic acid and iodine between unprocessed urine and urine expressed from a sanitary diaper to evaluate possible matrix effects on analytes.

    Time frame: 8-9 weeks after completion

Secondary outcomes

  1. Correlation of urinary biomarkers with food and supplement intake

    Correlation of dietary intake assessed by a food frequency questionnaire with urinary iodine and methylmalonic acid normalized to creatinine.

    Time frame: 8-9 weeks after completion

Other outcomes

  1. Mean difference of urinary biomarkers between groups

    Exploratory analysis of differences by dietary group in urinary iodine nomalized to creatinin.

    Time frame: 8-9 weeks after completion

  2. Mean difference of urinary biomarkers between groups

    Exploratory analysis of differences by dietary group in methylmalonic acid nomalized to creatinin.

    Time frame: 8-9 weeks after completion

07

Study locations

1 site
  • University of Hohenheim
    Stuttgart, Baden-Wuerttemberg 70599, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in May 2023, 2 months.

Of 174 non-industry observational studies under Malnutrition, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 41. This study's 2 months is below that.

Counting every sponsor, half of 186 studies reached it within 21 months; a quarter within 11 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 8, 2023
First posted
Mar 21, 2023
StartActual
Mar 8, 2023
Primary completionActual
May 9, 2023
CompletionActual
May 9, 2023
Last update
Nov 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05777356
Lead sponsor
University of Hohenheim
Responsible party
Maren Podszun (Dr. rer. nat. Maren Podszun, University of Hohenheim) — Principal investigator
First posted
Mar 21, 2023
Start date
Mar 8, 2023
Primary completion
May 9, 2023
Completion
May 9, 2023
Last update
Nov 28, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion